DA
NEO icon

Duality Advisers’s NeoGenomics NEO Stock Holding History

Duality Advisers’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-55,704
Closed -$876K – 359
2024
Q1 		$876K Buy
55,704
+42,876
+334% +$662K 0.09% 358
2023
Q4 		$208K Sell
12,828
-29,846
-70% -$488K 0.02% 544
2023
Q3 		$525K Sell
42,674
-9,942
-19% -$148K 0.06% 409
2023
Q2 		$846K Buy
+52,616
New +$867K 0.11% 314
2022
Q2 		– Sell
-132,820
Closed -$1.61M – 772
2022
Q1 		$1.61M Buy
+132,820
New +$2.79M 0.17% 203

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Duality Advisers's NEO Position: Q2 2024 in Review

Duality Advisers sold out of NeoGenomics (NEO) in Q2 2024, closing a stake of 55,704 shares — an estimated $876K sold.

Duality Advisers first reported a position in NEO in Q1 2022 and held it in 5 quarters. The position peaked at $1.61M in Q1 2022. 259 funds tracked by Wall St. Rank hold NEO as of Q2 2024.

  • Duality Advisers reported no remaining NeoGenomics position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 55,704 NeoGenomics shares in Q2 2024, an estimated $876K.
  • Duality Advisers first reported a position in NeoGenomics in Q1 2022 and held it in 5 quarters.
  • Duality Advisers's NeoGenomics position peaked at $1.61M in Q1 2022.
  • 259 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.